Afanat tablet is a tyrosine kinase inhibitor family of medication indicated for the treatment of: Non-Small Cell Lung Cancer (NSCLC); It is mainly used to treat cases of NSCLC that harbour mutations in the EGFR (Epidermal Growth Factor Receptor) gene.